Healthtech Startups

Altilia provides an enterprise AI platform that enables businesses to create, customize, and deploy AI agents without specialized technical skills. The platform combines generative AI capabilities with an intuitive interface designed for organizations across industries to automate workflows and enhance decision-making.

1 investor

Alto Pax provides a confidentiality-first group therapy platform that connects patients with specialized mental health clinicians, addressing the shortage of care access through measurement-based group care models rather than traditional 1:1 therapy.

1 investor

Altratech develops point-of-care diagnostic technology for quantitative HIV viral load testing in low- and middle-income countries. The company creates affordable and accessible medical devices for resource-limited healthcare settings.

1 investor

Altruix operates local, independent pharmacies in the mid-Atlantic region, offering person-centered pharmacy services that specialize in behavioral health, intellectual and developmental disabilities, and substance use disorder. It focuses on helping people access and adhere to their prescribed treatments.

1 investor

Altum Sequencing develops ultra-sensitive, tumor-informed liquid biopsy (ctDNA) tests paired with an AI-driven platform to detect cancer relapse and measure treatment response at the molecular level. It serves clinicians and researchers in oncology and hematology, covering both hematologic malignancies and solid tumors.

1 investor

Altus designs and manufactures mobile workstations, wall mounts, IoT-enabled carts, and OEM-integrated healthcare equipment for clinical and IT teams. The company produces all solutions in Michigan with locally sourced components.

1 investor

Altus provides fire alarm systems, sprinkler services, fire suppression equipment, fire extinguishers, and life safety solutions for building safety and emergency response.

1 investor

Alume Biosciences develops nerve illumination technology for surgery, including bevonescein (ALM-488), an injectable peptide that makes nerves glow to help surgeons identify and preserve them during procedures such as head-and-neck and prostate surgery. The drug candidate is in Phase 3 clinical trials, with a planned FDA New Drug Application submission in 2026.

1 investor

Alva Health develops wearable medical devices that continuously monitor for early signs of stroke and alert emergency responders in real time. The company serves patients at risk of stroke and the healthcare system, focusing on improving outcomes through rapid detection and treatment initiation.

1 investor

AlveoGene develops respiratory gene therapies, led by executives and academic researchers from the UK Respiratory Gene Therapy Consortium.

1 investor

Alveolus Bio develops inhaled biotherapeutics for chronic and infectious lung diseases, using a platform that delivers targeted bacteria to the lungs to treat conditions such as idiopathic pulmonary fibrosis, NCFBE, and COPD. It serves patients with chronic and infectious respiratory conditions in the biotechnology and pharmaceutical space.

1 investor

Alveus Pharmaceuticals is a pharmaceutical development company specializing in niche generic and specialty pharmaceutical products through internal product development and late-stage licensing. Based in Hyderabad, the company provides contract development services with a focus on affordability, safety, and compliance with international quality standards.

1 investor

ALVO Medical manufactures modular medical enclosure systems with materials including stainless steel, glass, and HPL panels designed for operating rooms and healthcare facilities. The company emphasizes durability, hygiene, and aesthetic design aligned with healing-focused interior concepts.

1 investor

Alvogen is a pharmaceutical company committed to making high-quality medicines more accessible through a focus on best people, portfolio, service, quality, and cost efficiency. The company serves customers globally in the pharmaceutical industry.

1 investor

Always Best Care provides in-home senior care, assisted living and senior community referral services, and skilled nursing care for seniors and people with special needs. It also offers specialized health monitoring technology and assistance for veterans navigating VA financing, serving families across the U.S. and Canada.

1 investor

Alyssum is a biotechnology company developing novel therapeutic drugs, with expertise in protein engineering, oncology, and clinical development. Its leadership includes veterans of multiple FDA-approved medicines and accelerated approvals.

1 investor

Alzprotect is a biotech company developing therapeutic candidates for neurodegenerative diseases, including tauopathies such as Progressive Supranuclear Palsy (PSP) and Alzheimer's disease. Its lead drug candidate targets multiple markers of neurodegeneration including amyloid beta peptide, Tau protein, neuroinflammation, and oxidative stress.

1 investor

American-Sino (美华) operates private hospitals and clinics in Shanghai, including a women's and children's hospital, medical centers, pediatric and maternity care facilities. It provides medical services across departments such as obstetrics and gynecology, pediatrics, dermatology, dentistry, traditional Chinese medicine, and general practice.

1 investor

Amaha is a mental healthcare provider in India offering therapy, psychiatry, hospital care, child and youth services, a moderated support community, and a self-help app for individuals, families, and organisations. It operates in-person centres across Bangalore, Mumbai, and Delhi alongside online care, serving people of all ages in 15+ Indian languages.

1 investor

Amalgent is a clinical-stage pain management company developing oral combination drug therapeutics that repurpose existing medications to improve the safety of severe pain treatment. It initially targets the US market.

1 investor

Amaron develops an Enterprise Application Integration platform that enables healthcare organizations to exchange data seamlessly between their systems and devices using Mirth Connect and open standards like HL7, FHIR, and DICOM.

1 investor

Amayu operates a platform in Germany that connects patients with ketamine therapy for psychiatric and chronic conditions, combining medical ketamine treatments delivered by independent partner physicians with accompanying psychological support. It coordinates in-practice sessions and online video consultations for conditions such as depression, anxiety, trauma, OCD, chronic pain, and addiction, currently offering treatment in Berlin with planned expansion to other German cities.

1 investor

AMBA provides supplemental insurance and benefits solutions to retired public employees, educators, alumni groups, and professional organizations across the United States. The company also offers specialized products including professional liability insurance for healthcare workers and event cancellation insurance.

1 investor

AmbioPharm is a contract manufacturer of custom peptide active pharmaceutical ingredients (APIs), providing process development, scale-up, and cGMP manufacturing for late-stage clinical and commercial peptide products. It serves pharmaceutical and biotech companies, clinical research labs, universities, and cosmetic formulators, and is expanding its North Augusta, South Carolina campus for U.S.-based commercial-scale peptide production.

1 investor